Provided by Tiger Trade Technology Pte. Ltd.

Kyverna Therapeutics

8.08
+0.15001.89%
Post-market: 8.080.00000.00%16:10 EST
Volume:517.08K
Turnover:4.12M
Market Cap:461.61M
PE:-2.17
High:8.18
Open:8.05
Low:7.66
Close:7.93
52wk High:13.67
52wk Low:1.78
Shares:57.13M
Float Shares:33.30M
Volume Ratio:0.63
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7205
EPS(LYR):-3.3254
ROE:-70.82%
ROA:-40.75%
PB:3.04
PE(LYR):-2.43

Loading ...

Company Profile

Company Name:
Kyverna Therapeutics
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
129
Office Location:
5980 Horton Street,Suite 550,Emeryville,California,United States
Zip Code:
94608
Fax:
- -
Introduction:
- -

Directors

Name
Position
Warner Weston Biddle
Chief Executive Officer and Director
Beth Seidenberg
Independent Director
Christi Shaw
Executive Chairperson of the Board
Daniel K. Spiegelman
Independent Director
Fred E. Cohen
Independent Director
Mert Aktar
Independent Director
Ian Clark
Director

Shareholders

Name
Position
Warner Weston Biddle
Chief Executive Officer and Director
Marc Grasso
Chief Financial Officer and Principal Accounting Officer
Christi Shaw
Executive Chairperson of the Board
Mayo Pujols
Chief Technology Officer
Naji H. Gehchan
Chief Medical and Development Officer